MTAC
NASDAQ:MTACU
MedTech Acquisition Corporation
- Stock
Last Close
9.56
10/08 20:00
Market Cap
83.86M
Beta: −0.03
Volume Today
176.27K
Avg: 58
PE Ratio
−2.71
PFCF: −8.68
Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
---|---|---|---|---|---|
asset turnover | 0.72 - | ||||
cash conversion cycle | -48.46 - | ||||
cash per share | 0.04 - | 0.01 84.95% | 0.00 23.56% | ||
company equity multiplier | 1.04 - | 1.07 3.62% | 3.09 187.72% | -0.99 132.10% | |
days of inventory outstanding | 356.59 - | ||||
days of payables outstanding | 475.13 - | ||||
days of sales outstanding | 70.08 - | ||||
dividend yield | |||||
ebit per revenue | -2.93 - | ||||
ebt per ebit | -1.57 - | -2.22 41.91% | 1.09 148.99% | ||
effective tax rate | -1.64 - | 0.09 105.70% | -0.00 100.16% | ||
enterprise value multiple | -28.66 - | -36.77 28.31% | 0.19 100.52% | ||
fixed asset turnover | 5.66 - | ||||
free cash flow per share | -0.06 - | -0.09 57.47% | |||
gross profit margin | 0.86 - | ||||
interest coverage | 0.31 - | -3.38K 1,091,536.89% | |||
inventory turnover | 1.02 - | ||||
long term debt to capitalization | 0.00 - | 0.17 7,219.89% | -0.05 129.58% | ||
net income per ebt | 2.64 - | 0.91 65.63% | 1.00 10.32% | ||
net profit margin | -3.19 - | ||||
operating cash flow per share | -0.06 - | -0.09 57.47% | |||
operating cycle | 426.67 - | ||||
operating profit margin | -2.93 - | ||||
payables turnover | 0.77 - | ||||
pretax profit margin | -3.19 - | ||||
price fair value | 1.35 - | 1.32 2.11% | 47.97 3,524.81% | ||
receivables turnover | 5.21 - | ||||
return on assets | 0.05 - | 0.27 446.63% | -2.29 936.43% | ||
return on capital employed | -0.01 - | -0.16 1,173.94% | -4.91 3,059.45% | ||
return on equity | 0.05 - | 0.85 1,472.75% | 2.28 168.47% | ||
total debt to capitalization | 0.00 - | 0.27 11,349.38% | -0.07 124.60% |
All numbers in USD (except ratios and percentages)